Big Move For Corvus Pharmaceuticals, Inc.
Wed, May 17, 2023 at 07:44 PM
Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) soared at $3.24, a gain of 36.7%. On Wed, May 17, 2023, CRVS:NASDAQ hit a New 2-Week High of $3.24. The stock appeared on our News Catalysts scanner on Wed, May 17, 2023 at 11:14 AM in the 'MISCELLANEOUS' category. From Wed, May 03, 2023, the stock recorded 80.00% Up Days and 81.82% Green Days
About Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ)
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company. It is engaged in development and commercialization of novel immuno-oncology therapies that are designed to harness the immune system to attack cancer cells.
Top 10 Gainers:
- Aspen Group, Inc. (ASPU:NASDAQ), 179.3%
- Immutep Limited (IMMP:NASDAQ), 64.78%
- Peak Bio Inc Com (PKBO:NASDAQ), 48.12%
- National Western Life Group, Inc. (NWLI:NASDAQ), 46.32%
- Smart for Life Inc. (SMFL:NASDAQ), 44.4%
- SelectQuote Inc. (SLQT:NYSE), 41.67%
- Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ), 41.09%
- Motus GI Holdings, Inc. (MOTS:NASDAQ), 38.75%
- Viracta Therapeutics Inc. (VIRX:NASDAQ), 37.35%
- Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ), 36.71%